Summary
Brain choline acetyltransferase (ChAT) activity was determined in 43 patients with Alzheimer's disease (AD), 14 with multi-infarct dementia (MID), and 15 with combined dementia (CD) and in 53 age-matched controls. The activity of ChAT declined in the hippocampus, temporal and frontal cortex in patients with AD and CD compared to the controls. In the AD group the reduced activity of ChAT in all brain areas was associated with a greater number of cortical neurofibrillary tangles. The degree of dementia had a negative correlation with the activity of ChAT in the frontal cortex in both AD and CD patients. The activity of ChAT in the temporal cortex of CD patients was negatively associated with the cortical tangle counts. In contrast, the activity of ChAT and MID patients was not essentially different from that of the controls. Neither did the various clinical and neuropathological variables show any significant correlation with ChAT activity in MID patients. Thus, in this study the reduction in the activity of ChAT seems to be associated with Alzheimer-type pathology but not with dementia due to vascular changes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bowen DM, Smith CB, White P, Davidson AN (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99: 459–496
Canter GJ, LaTorre R, Mier M (1961) A method for evaluating disability in patients with Parkinson's disease. J Nerv Ment Dis 133: 143–147
Davies P, Maloney AJF (1976) Selective loss of cholinergic neurons in Alzheimer's disease. Lancet ii: 1403
Dixon WJ (1983) BMDP statistical software. University of California Press, Berkeley, CA
Fonnum F (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 24: 407–409
Gerlach J (1979) Tardive dyskinesia. Academic dissertation, Laegeforeningens förlag, Copenhagen
Isaacs B, Walkey FA (1964) Measurement of mental impairment in geriatric practice. Gerontol Clin 6: 114–123
Mash CD, Flynn DD, Potter LT (1985) Loss of muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholingeric denervation. Science 228: 1115–1117
Mountjoy CQ, Rossor MN, Iversen LL, Roth M (1984) Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia. Brain 107: 507–518
Mölsä PK, Säkö E, Paljärvi L, Rinne JO, Rinne UK (1987) Alheimer's disease: neuropathological correlates of cognitive and motor disorders. Acta Neurol Scand 75: 376–384
Nordberg A, Larsson C, Adolfsson R, Alafuzoff I, Winblad B (1983) Muscarinic receptor compensation in hippocampus of Alzheimer patients. J Neural Transm 56: 13–19
Overall IE, Corham DR (1962) The brief psychiatric rating scale. Psychol Rep 10: 799–812
Perry EK, Perry RM, Blessed G, Tomlinson BE (1977) Necropsy evidence of central cholinergic deficits in senile dementia. Lancet i: 189
Perry EK, Tomlinson BE, Blessed G, Bergman K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2: 1457–1459
Reisine TD, Yamamura HI, Bird ED, Spokes E, Enna SJ (1978) Pre- and postsynaptic neurochemical alterations in Alzheimer's disease. Brain Res 159: 477–480
Rinne JO, Laakso K, Lönnberg P, Mölsä P, Paljärvi L, Rinne JK, Säkö E, Rinne UK (1985) Brain muscarinic receptors in senile dementia. Brain Res 336: 19–25
Rinne UK, Lönnberg P, Koskinen V (1981) Dopamine receptors in the parkinsonian brain. J Neural Transm 51: 97–106
Ruberg M, Ploska A, Javoy-Agid F, Agid Y (1982) Muscarinic binding and choline acetyltransferase activity in Parkinson subjects with reference to dementia. Brain Res 232: 129–139
Shimohama S, Taniguchi T, Fujuwara M, Kameyama M (1986) Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia. J Neurochem 46: 288–293
Whitehouse PJ, Martino AM, Antuono PG, Lowenstein PR, Coyle J, Price DL, Kellar K (1986) Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res 371: 146–151
Wilcock GK, Esiri MM, Bowen DM, Smith CCT (1982) Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci 57: 407–417
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rinne, J.O., Säkö, E., Paljärvi, L. et al. A comparison of brain choline acetyltransferase activity in Alzheimer's disease, multi-infarct dementia, and combined dementia. J. Neural Transmission 73, 121–128 (1988). https://doi.org/10.1007/BF01243383
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01243383